New US product launch, VENXXIVA™ (tiopronin) Delayed-Release Tablets for the treatment of cystinuria
Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment of cystinuria, approved by the US Food and Drug Administration (FDA) ...
New Delhi: Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...
The global Pharmacy Automation Market, valued at US$6.23 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, ...
A pharmacist in Grande Prairie stole from his employer, forged prescriptions, created false transaction records and diverted ...
16d
Belfast Live on MSNBoots issues urgent recall of paracetamol tablets due to 'packaging error'Boots has issued an urgent recall notice on paracetamol tablets due to a “packaging error”. It comes after 500mg packs of the ...
WPBF West Palm Beach on MSN6d
CVS pharmacy employee busted for stealing opioid pillsCVS higher-ups became suspicious when they took inventory and realized that they were missing hundreds of individual narcotics tablets of varying drug types.
Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment of cystinuria, approved by the US Food and Drug Administration (FDA) ...
The Express has recently highlighted that celebrities like Taylor Swift are big fans of magnesium. It's a vital mineral that the NHS recommends should be part of everyone's daily nutrition in a ...
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
1d
Stockhead on MSNThe ASX pharmas playing the long game, with commercialisation the prizeASX pharmaceutical companies are retaining their assets longer and advancing them to commercialisation in a bid to maximise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results